UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2187-2191

2015

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis

Journal of thrombosis and haemostasis, 2017-06, Vol.15 (6), p.1142-1154

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

BMJ (Online), 2011-05, Vol.342, p.d3036

2011

Link zum Volltext

Verfügbarkeit prüfen

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test

European heart journal, 2011-07, Vol.32 (13), p.1657-1663

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

British journal of surgery, 2005-10, Vol.92 (10), p.1212-1220

2005

Link zum Volltext

Verfügbarkeit prüfen

Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events

European heart journal, 2010-06, Vol.31 (12), p.1449-1456

2010

Link zum Volltext

Verfügbarkeit prüfen

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1959-1965

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.746-753

2007

Link zum Volltext

Verfügbarkeit prüfen

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619883946-1076029619883946

2019

Link zum Volltext

Verfügbarkeit prüfen

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1660-1665

2007

Link zum Volltext

Verfügbarkeit prüfen

Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular events

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2599-2606

2006

Link zum Volltext

Verfügbarkeit prüfen

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Thrombosis research, 2018-10, Vol.170, p.165-174

2018

Link zum Volltext

Verfügbarkeit prüfen

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

European heart journal, 2007-07, Vol.28 (14), p.1717-1722

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.1081-1083

2011

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars of low‐molecular‐weight heparin products: fostering competition or reducing ‘biodiversity’?

Journal of thrombosis and haemostasis, 2016-03, Vol.14 (3), p.421-426

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists

European journal of internal medicine, 2016-09, Vol.33, p.47-54

2016

Link zum Volltext

Verfügbarkeit prüfen

Pain management in Internal Medicine and effects of a standardised educational intervention: the FADOI-DOMINO Study

International journal of clinical practice (Esher), 2015-01, Vol.69 (1), p.33-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Aspirin for Preventing the Recurrence of Venous Thromboembolism

The New England journal of medicine, 2012-05, Vol.366 (21), p.1959-1967

2012

Link zum Volltext

Verfügbarkeit prüfen

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Journal of thrombosis and haemostasis, 2003-12, Vol.1 (12), p.2490-2496

2003

Link zum Volltext

Verfügbarkeit prüfen

Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case–control study

Journal of neurology, neurosurgery and psychiatry, 2006-01, Vol.77 (1), p.95-97

2006

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1218-1223

2005

Link zum Volltext

Verfügbarkeit prüfen

Performance of recalibrated ReFacto® laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto® (B-domain deleted recombinant factor VIII)

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.779-787

2009

Link zum Volltext

Verfügbarkeit prüfen

More on: vitamin K antagonists and cancer

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1441-1442

2008

Link zum Volltext

Verfügbarkeit prüfen

Isolated monoparesis following stroke

Journal of neurology, neurosurgery and psychiatry, 2005-06, Vol.76 (6), p.805-807

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular events

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

Biosimilars of low‐molecular‐weight heparin products: fostering competition or reducing ‘biodiversity’?

Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists

Pain management in Internal Medicine and effects of a standardised educational intervention: the FADOI-DOMINO Study

Aspirin for Preventing the Recurrence of Venous Thromboembolism

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism

Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case–control study

Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

Performance of recalibrated ReFacto® laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto® (B-domain deleted recombinant factor VIII)

More on: vitamin K antagonists and cancer

Isolated monoparesis following stroke

Aktive Filter

Suchergebnisse filtern